Natural killer-cell KIR repertoire reconstitution after haploidentical SCT

M Stern1, C de Angelis, E Urbani

  • 1Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy. sternm@uhbs.ch

Bone Marrow Transplantation
|February 23, 2010
PubMed
Summary

Donor-derived natural killer (NK) cell repertoires after haploidentical stem cell transplant (SCT) impact leukemia survival. Specifically, HLA-C1 mismatching in the graft-versus-host direction significantly improves event-free survival (EFS) in acute myeloid leukemia (AML) patients.

Related Concept Videos